BofA Global Research cuts United Therapeutics price target to $613 from $620
UTHR•Related News

Tectonic Therapeutic CSO Peter McNamara reports TECX common share disposal worth $1,505 on Aug. 12
TECX•

Conrad Industries Q2 FY26 net income drops 43.1% to $3.3 million; EPS falls 43.97% to $0.65
CNRD•

Kratos CEO Eric DeMarco disposes of USD 19.32 million in common shares
KTOS•

AppFolio 10% owner Maurice J. Duca sells USD 2.52 million in common shares
APPF•

Cosan fiscal council backs total spinoff of Radar II, winding down farm property unit
CSAN•